Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures

NCT: NCT04821739 · ACTIVE_NOT_RECRUITING

NCT IDNCT04821739
StatusACTIVE_NOT_RECRUITING
Start Date2021-05-19
Completion2028-12-01

Brief Summary

This study is a prospective, single-arm, multi-center, European clinical study designed to evaluate the clinical performance and safety of the AGN1 LOEP SV Kit for the treatment of painful VCFs.

Frequently Asked Questions

What is RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures?

RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures is a clinical trial registered under NCT04821739. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04821739?

The current status of NCT04821739 (RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures) is: ACTIVE_NOT_RECRUITING.

When did RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures start?

RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures started on 2021-05-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑